![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
1 National Institutes of Health, National Heart Institute, Laboratory of Chemical Pharmacology, Bethesda, Maryland
A new method of measuring the rate of synthesis of brain serotonin (5-HT) takes advantage of the steady state relationship in which the molar rates of 5-HT synthesis and 5-hydroxyindoleacetic acid (5-HIAA) efflux are equal. The method is based on the dynamic steady state of 5-HT and its metabohte 5-HIAA, with rates of formation equal to rates of metalbolism and elimination. After monoamine oxidase was blocked with a number of inhibitors, including pargyline and tranylcypromine, the brain levels of 5-HIAA decline exponentially. The rate of synthesis of 5-HT is calculated from the product of the rate constant of 5-HIAA decline and the normal 5-HIAA level. After depletion of 5-HT stores by reserpine, the 5-HT synthesis rate is not decreased; in fact, the rate possibly may be increased. In the brain stem, 5-HT is formed twice as rapidly as in the rest of the brain, although the rate constants of 5-HIAA efflux are almost identical. This suggests that the rate of synthesis might be similar in each serotonergic unit, and that variations in rates of synthesis in different brain areas are a function of the number of neurons per gram of tissue.
Accepted on March 10, 1966
This article has been cited by other articles:
|
|
 |
|
  B. A. Horwitz, J. S. Hamilton, V. H. Routh, K. Green, P. Havel, and A. Chan Adiposity and serum leptin increase in fatty (fa/fa) BNZ neonates without decreased VMH serotonergic activity Am J Physiol Endocrinol Metab, June 1, 1998; 274(6): E1009 - E1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Denney, R. Fritz, N. Patel, and C. Abell Human liver MAO-A and MAO-B separated by immunoaffinity chromatography with MAO-B-specific monoclonal antibody Science, March 12, 1982; 215(4538): 1400 - 1403. [Abstract] [PDF]
|
|
|
|
|
|
R. J. Hitzemann, I. K. Ho, H. H. Loh, D. L. Cheney, and E. Costa Narcotic Tolerance and Dependence and Serotonin Turnover Science, November 10, 1972; 178(4061): 645 - 647. [PDF]
|
|
|
|
|
|
M. Bulat and B. Zcaronivkovicacute Origin of 5-Hydroxyindoleacetic Acid in the Spinal Fluid Science, August 20, 1971; 173(3998): 738 - 740. [Abstract] [PDF]
|
|
|
|
|
|
K. M. Taylor and S. H. Snyder Brain Histamine: Rapid Apparent Turnover Altered by Restraint and Cold Stress Science, June 4, 1971; 172(3987): 1037 - 1039. [Abstract] [PDF]
|
|
|
|
|
|
G. K. Aghajanian, A. W. Graham, and M. H. Sheard Serotonin-Containing Neurons in Brain: Depression of Firing by Monoamine Oxidase Inhibitors Science, September 11, 1970; 169(3950): 1100 - 1102. [Abstract] [PDF]
|
|
|
|
|
|
R. C. Lin, S. H. Ngai, and E. Costa Lysergic Acid Diethylamide: Role in Conversion of Plasma Tryptophan to Brain Serotonin (5-Hydroxytryptamine) Science, October 10, 1969; 166(3902): 237 - 239. [Abstract] [PDF]
|
|
|
|
|
|
E. L. Way, H. H. Loh, and F.-h. Shen Morphine Tolerance, Physical Dependence, and Synthesis of Brain 5-Hydroxytryptamine Science, December 13, 1968; 162(3859): 1290 - 1292. [Abstract] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
